You're one step closer to unlocking our suite of comprehensive and robust tools.
Fill out the form so we can connect you to the right person.
If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.
Eurofins to acquire Villapharma in Spain
Brazil Pay TV Down Record Amount In 2019, With Losses Continuing In Q1'20
Impact of COVID 19 on US Video Entertainment Trends
Case Study: Transforming Sales Enablement Data at a Global Advertising and Media Firm
Key Credit Risk Factors When Assessing Banks In The Context Of COVID-19
Eurofins Scientific SE is acquiring Villapharma Research SL in Spain for undisclosed terms.
The transaction is expected to close in February 2017 and will help Eurofins reinforce its footprint in discovery pharmacology.
Villapharma is a provider of organic synthesis and medical chemistry services to pharmaceutical and biotech companies. The company is expected to generate more than €6 million in revenues this year.